Pharmaceutical Technology42m
A2 Biotherapeutics raises $80m to advance CAR-T therapies for solid tumours
A2 Biotherapeutics has secured $80m in funding to advance its pipeline of CAR-T cell therapies for solid tumour cancers.
Pharmaceutical Technology52m
Light Horse emerges with $62m and Novartis partnership worth up to $1bn
Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.
Pharmaceutical Technology1h
Coave Therapeutics raises $33m in funding to advance ALIGATER platform
Coave has raised €32m ($33m) in a Series A financing round for advancing its Advanced Vectors-Ligand Conjugates (ALIGATER) platform.
Pharmaceutical Technology5h
Synaffix secures ADC deals with Boehringer and Mitsubishi Tanabe
Synaffix adds to the flurry of ADC dealmaking as it partners with Boehringer and Mitsubishi Tanabe with deals announced on the same day.
Pharmaceutical Technology22h
Samsung Biologics and LigaChem extend ADC services deal
Samsung Biologics has extended its collaboration with LigaChem Biosciences for antibody-drug conjugate (ADC) services.